Search
for
Sort by
Research 31–60 of 1000+
- Veterinary Pharmacology
- Systemic treatments for alopecia areata: A systematic review
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Survey on adverse events associated with drug therapy for breast cancer patients
- Reporting on Adverse Clinical Events
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Cemiplimab-Induced Alopecia Areata
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- Proposal for Clinical Classification of Cutaneous Manifestations in Covid-19 and in Post Vaccination Against Sars-Cov-2: An Observational Study
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series
- 785 Single-cell transcriptomic profile of EGFR-deficient epidermal compartments during folliculitis
- Adipose Tissue–Derived Exosomes as a Novel Therapeutic Approach for Refractory Alopecia Areata: A Report of Two Cases
- Aim to alleviate alopecia areata with newly available agents
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Sex hormones and related compounds, including hormonal contraceptives